Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00761_DB00771_nanopub.RADNSQp6FXy_CTND2D0sbO5FLxyHka9fG98X0AQwFp7g0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00761_DB00771 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00761_DB00771 label "DDI between Potassium Chloride and Clidinium - Anticholinergic agents such as clidinium may enhance the ulcerogenic effect of potassium chloride. Solid oral dosage forms of potassium chloride are contraindicated in patients with impaired gastric emptying (e.g., due to the effects of drugs such as many anticholinergics). Patients on drugs with substantial anticholinergic effects should avoid using any solid oral dosage form of potassium chloride; liquid or effervescent potassium preparations are possible alternatives. [drugbank_resource:DB00761_DB00771]" assertion.
- drugbank_resource:DB00761_DB00771 identifier "drugbank_resource:DB00761_DB00771" assertion.
- drugbank_resource:DB00761_DB00771 title "DDI between Potassium Chloride and Clidinium - Anticholinergic agents such as clidinium may enhance the ulcerogenic effect of potassium chloride. Solid oral dosage forms of potassium chloride are contraindicated in patients with impaired gastric emptying (e.g., due to the effects of drugs such as many anticholinergics). Patients on drugs with substantial anticholinergic effects should avoid using any solid oral dosage form of potassium chloride; liquid or effervescent potassium preparations are possible alternatives." assertion.
- drugbank:DB00761 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00761_DB00771 assertion.
- drugbank:DB00771 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00761_DB00771 assertion.